Skip to content

Huysse MedConsult

Active
Private limited company·Speur- en ontwikkelingswerk op biotechnologisch gebied· 4 yrs active
Koutemstraat 34 ·3370 Boutersem, Belgium
BE 0778.801.122
Watch Print / PDF
Turnover
EBIT margin
Net result€66k
Working capital€53k-10.9%

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Huysse MedConsult is 0.8% (low). The 2025 annual accounts show equity of €52k and a net result of €66k. Equity is shrinking by ~13.1% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Trust signals

3 signals
More than 3 years active
Founded in 2021 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.8% Low
0%0,5%1,5%4%10%≥25%
Young company +Lower-failure-rate sector Annual accounts: healthy financial profile

Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?

Company registry (CBE)

Crossroads Bank
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Overige dienstverlenende activiteiten op het gebied van informatie63920Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.63990
Primary activity highlighted.
Names & trade names
Legal nameNL Huysse MedConsult
AbbreviationNL HMC
Registered office
Koutemstraat 34
3370 Boutersem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.